MACQUARIE GROUP LTD - ZIOPHARM ONCOLOGY INC ownership

ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 170 filers reported holding ZIOPHARM ONCOLOGY INC in Q4 2021. The put-call ratio across all filers is 0.54 and the average weighting 0.0%.

Quarter-by-quarter ownership
MACQUARIE GROUP LTD ownership history of ZIOPHARM ONCOLOGY INC
ValueSharesWeighting
Q1 2022$18,000
-41.9%
28,0770.0%0.00%
Q4 2021$31,000
-39.2%
28,0770.0%0.00%
Q3 2021$51,000
+218.8%
28,077
+350.8%
0.00%
Q2 2021$16,000
-27.3%
6,2280.0%0.00%
Q1 2021$22,000
+4.8%
6,228
-23.5%
0.00%
Q4 2020$21,0000.0%8,1380.0%0.00%
Q3 2020$21,000
-22.2%
8,1380.0%0.00%
Q2 2020$27,0008,1380.00%
Other shareholders
ZIOPHARM ONCOLOGY INC shareholders Q4 2021
NameSharesValueWeighting ↓
DISCOVERY CAPITAL MANAGEMENT, LLC / CT 14,013,093$9,142,0000.78%
MSD Partners, L.P. 15,151,516$9,885,0000.54%
MSD Partners, L.P. 7,575,758$4,942,0000.27%
CHIRON CAPITAL MANAGEMENT, LLC 144,960$95,0000.06%
MAGNOLIA CAPITAL ADVISORS LLC 185,456$121,0000.05%
Allred Capital Management, LLC 128,000$83,0000.04%
Virtus ETF Advisers LLC 131,413$86,0000.04%
GSA CAPITAL PARTNERS LLP 232,438$152,0000.02%
ACT WEALTH MANAGEMENT, LLC 37,071$24,0000.01%
Pathway Financial Advisors LLC 30,000$20,0000.01%
View complete list of ZIOPHARM ONCOLOGY INC shareholders